Schroder Investment Management Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,269
| Closed | -$319K | – | 1391 |
|
|
2022
Q1 | $319K | Sell |
4,269
-268
| -6% | -$20K | ﹤0.01% | 1265 |
|
|
2021
Q4 | $676K | Sell |
4,537
-2,597
| -36% | -$387K | ﹤0.01% | 1082 |
|
|
2021
Q3 | $1.04M | Buy |
7,134
+3,850
| +117% | +$560K | ﹤0.01% | 1095 |
|
|
2021
Q2 | $643K | Sell |
3,284
-13,956
| -81% | -$2.73M | ﹤0.01% | 1201 |
|
|
2021
Q1 | $3.12M | Sell |
17,240
-4,712
| -21% | -$853K | ﹤0.01% | 925 |
|
|
2020
Q4 | $3.11M | Buy |
21,952
+962
| +5% | +$136K | ﹤0.01% | 914 |
|
|
2020
Q3 | $2.69M | Buy |
20,990
+1,510
| +8% | +$193K | ﹤0.01% | 842 |
|
|
2020
Q2 | $1.74M | Buy |
19,480
+3,345
| +21% | +$299K | ﹤0.01% | 847 |
|
|
2020
Q1 | $1.01M | Hold |
16,135
| – | – | ﹤0.01% | 903 |
|
|
2019
Q4 | $1.23M | Sell |
16,135
-3,865
| -19% | -$295K | ﹤0.01% | 940 |
|
|
2019
Q3 | $1.01M | Buy |
+20,000
| New | +$1.01M | ﹤0.01% | 985 |
|